Single-Cell Transcriptome Analysis of Peripheral Neutrophils From Patients With Idiopathic Pulmonary Arterial Hypertension
暂无分享,去创建一个
W. Kuebler | Lan Wang | Qinhua Zhao | R. Jiang | S. Gong | Jing He | Rui Zhang | H. Qiu | Jiantong Zhao | Yun-Long Zhang | Shao-Fei Liu | Ji Zhang | Hui-Ting Li | Xiao-Juan Wang
[1] Xue Yu,et al. Mechanistic insight into premature atherosclerosis and cardiovascular complications in systemic lupus erythematosus. , 2022, Journal of autoimmunity.
[2] M. Snyder,et al. Endogenous Retroviral Elements Generate Pathologic Neutrophils in Pulmonary Arterial Hypertension , 2022, American journal of respiratory and critical care medicine.
[3] N. Morrell,et al. New Mutations and Pathogenesis of Pulmonary Hypertension: Progress and Puzzles in Disease Pathogenesis , 2022, Circulation research.
[4] S. Dell’Orso,et al. Single-Cell Analysis Reveals the Range of Transcriptional States of Circulating Human Neutrophils , 2022, The Journal of Immunology.
[5] Min Liu,et al. Cell landscape atlas for patients with chronic thromboembolic pulmonary hypertension after pulmonary endarterectomy constructed using single-cell RNA sequencing , 2021, Aging.
[6] M. Yeager,et al. Metalloproteinases and Their Inhibitors Are Associated with Pulmonary Arterial Stiffness and Ventricular Function in Pediatric Pulmonary Hypertension. , 2021, American journal of physiology. Heart and circulatory physiology.
[7] A. Sweatt,et al. Severe Pulmonary Arterial Hypertension Is Characterized by Increased Neutrophil Elastase and Relative Elafin Deficiency , 2021, Chest.
[8] Jason D. Buenrostro,et al. The neutrotime transcriptional signature defines a single continuum of neutrophils across biological compartments , 2021, Nature Communications.
[9] Zhi-jie Liu,et al. Structural insights into the activation of chemokine receptor CXCR2 , 2021, The FEBS journal.
[10] S. Pullamsetti,et al. Matrix Metalloproteinase-8 in Pulmonary Hypertension: The Sheep in the Wolf’s Skin? , 2021, American journal of respiratory and critical care medicine.
[11] E. J. Dougherty,et al. Type I interferon activation and endothelial dysfunction in caveolin-1 insufficiency-associated pulmonary arterial hypertension , 2021, Proceedings of the National Academy of Sciences.
[12] W. Kuebler,et al. Perivascular Inflammation in Pulmonary Arterial Hypertension , 2020, Cells.
[13] T. Cheng,et al. Single-cell transcriptome profiling reveals neutrophil heterogeneity in homeostasis and infection , 2020, Nature Immunology.
[14] M. Dunning,et al. Whole-Blood RNA Profiles Associated with Pulmonary Arterial Hypertension and Clinical Outcome , 2020, American journal of respiratory and critical care medicine.
[15] Qingbo Xu,et al. Adventitial Cell Atlas of wt (Wild Type) and ApoE (Apolipoprotein E)-Deficient Mice Defined by Single-Cell RNA Sequencing , 2019, Arteriosclerosis, thrombosis, and vascular biology.
[16] M. Humbert,et al. Pathology and pathobiology of pulmonary hypertension: state of the art and research perspectives , 2019, European Respiratory Journal.
[17] Michael J. T. Stubbington,et al. Single-cell reconstruction of the early maternal–fetal interface in humans , 2018, Nature.
[18] M. Rabinovitch,et al. The Role of Neutrophils and Neutrophil Elastase in Pulmonary Arterial Hypertension , 2018, Front. Med..
[19] D. Lenschow,et al. ISG15 in antiviral immunity and beyond , 2018, Nature Reviews Microbiology.
[20] Jia Gu,et al. fastp: an ultra-fast all-in-one FASTQ preprocessor , 2018, bioRxiv.
[21] W. Kuebler,et al. Inflammation and autoimmunity in pulmonary hypertension: is there a role for endothelial adhesion molecules? (2017 Grover Conference Series) , 2018, Pulmonary circulation.
[22] J. Huibregtse,et al. Extracellular ISG15 Signals Cytokine Secretion through the LFA-1 Integrin Receptor. , 2017, Molecules and Cells.
[23] A. West,et al. Mitochondrial DNA in innate immune responses and inflammatory pathology , 2017, Nature Reviews Immunology.
[24] W. Seeger,et al. Biomarkers of tissue remodeling predict survival in patients with pulmonary hypertension. , 2016, International journal of cardiology.
[25] M. Humbert,et al. Interferon-induced pulmonary hypertension: an update , 2016, Current opinion in pulmonary medicine.
[26] R. Goodacre,et al. Electronic cigarette exposure triggers neutrophil inflammatory responses , 2016, Respiratory Research.
[27] A. Heger,et al. UMI-tools: modeling sequencing errors in Unique Molecular Identifiers to improve quantification accuracy , 2016, bioRxiv.
[28] S. Bozkurt,et al. Prognostic value of neutrophil-to-lymphocyte ratio in pulmonary arterial hypertension , 2015, The Journal of international medical research.
[29] Hai Li,et al. Elafin Reverses Pulmonary Hypertension via Caveolin-1-Dependent Bone Morphogenetic Protein Signaling. , 2015, American journal of respiratory and critical care medicine.
[30] M. Humbert,et al. Pulmonary arterial hypertension in patients treated with interferon , 2014, European Respiratory Journal.
[31] M. Humbert,et al. Inflammation and immunity in the pathogenesis of pulmonary arterial hypertension. , 2014, Circulation research.
[32] W. Seeger,et al. Matrix metalloproteinases and their inhibitors in pulmonary hypertension , 2012, European Respiratory Journal.
[33] D. Budd,et al. Bone morphogenetic protein receptor II regulates pulmonary artery endothelial cell barrier function. , 2011, Blood.
[34] R. Trembath,et al. Elevated Levels of Inflammatory Cytokines Predict Survival in Idiopathic and Familial Pulmonary Arterial Hypertension , 2010, Circulation.
[35] B. Heissig,et al. Role of neutrophil-derived matrix metalloproteinase-9 in tissue regeneration. , 2010, Histology and histopathology.
[36] P. Bruijnzeel,et al. The pathogenesis of photoaging: the role of neutrophils and neutrophil-derived enzymes. , 2009, The journal of investigative dermatology. Symposium proceedings.
[37] C. Lloyd,et al. Three-colour fluorescence immunohistochemistry reveals the diversity of cells staining for macrophage markers in murine spleen and liver. , 2008, Journal of immunological methods.
[38] R. Speich,et al. Peripheral blood B lymphocytes derived from patients with idiopathic pulmonary arterial hypertension express a different RNA pattern compared with healthy controls: a cross sectional study , 2008, Respiratory research.
[39] R. Tal-Singer,et al. A novel flow cytometric assay of human whole blood neutrophil and monocyte CD11b levels: upregulation by chemokines is related to receptor expression, comparison with neutrophil shape change, and effects of a chemokine receptor (CXCR2) antagonist. , 2007, Pulmonary pharmacology & therapeutics.
[40] A. Lindén. Interleukin-17 and airway remodelling. , 2006, Pulmonary pharmacology & therapeutics.
[41] M. Frid,et al. Hypoxia-induced pulmonary vascular remodeling requires recruitment of circulating mesenchymal precursors of a monocyte/macrophage lineage. , 2006, The American journal of pathology.
[42] F. Nielsen,et al. The transcriptional program of terminal granulocytic differentiation. , 2004, Blood.
[43] M. Humbert,et al. Cellular and molecular pathobiology of pulmonary arterial hypertension. , 2004, Journal of the American College of Cardiology.
[44] W. Seeger,et al. Increased neutrophil mediator release in patients with pulmonary hypertension – suppression by inhaled iloprost , 2003, Thrombosis and Haemostasis.
[45] P. E. Van den Steen,et al. Neutrophil Gelatinase B and Chemokines in Leukocytosis and Stem Cell Mobilization , 2002, Leukemia & lymphoma.
[46] Thomas R. Gingeras,et al. STAR: ultrafast universal RNA-seq aligner , 2013, Bioinform..